1、李晓波,贾楠#. 肾动脉肌纤维发育不良的诊断治疗进展. 心血管微创医学杂志,2012;1(1):91- 97
2、Jia N*,Dong P,Ye Y,Qian C,Dai Q. Allopurinol attenuates oxidative stress and cardiac fibrosis in angiotensin II-induced cardiac diastolic dysfunction. Cardiovasc Ther,2012;30(2):117-123
3、P Dong, M Karaayvaz, N Jia*, M Kaneuchi, J Hamada, H Watari, S Sudo, J Ju and N Sakuragi. Mutant p53 gain-of-function induces epithelial-mesenchymal transition through modulation of the miR-130b-ZEB1 axis. Oncogene,2012;00:00-00
4、Li X, Li Y, Jia N#, Guo S, Chu S, Niu W. Angiotensin-converting enzyme gene deletion allele increases the risk of left ventricular hypertrophy: evidence from a meta-analysis. Mol Biol Rep,2012;00:00-00
5、Li Y, Li X, Jia N#, Guo S, Chu S, Niu W. Meta-analysis of the association between angiotensin II receptor, type 1 gene A1166C polymorphism and coronary artery disease in Chinese populations.. J Renin Angiotensin Aldosterone Syst,2012;00:00-00
6、叶瑛,贾楠#. 肾素-血管紧张素醛固酮系统与肾动脉狭窄. 临床内科杂志,2011;28:8-9
7、贾楠*. 肾动脉支架术：随机临床试验与临床实践的矛盾统一. 中华医学信息导报,2011;26(18):20-21
8、李晓波,贾楠#. 欧洲心脏病学会2011年关于肾动脉疾病的指南内容. 中国全科医学,2011;11:6-9
9、叶瑛,贾楠#. 瑞舒伐他汀的临床研究进展. 中国新药与临床杂志,2010;:29:813-815
10、叶瑛,贾楠#. 高尿酸血症-心血管事件的独立危险因素. 国际心血管病杂志,2010;37:229-231
11、叶瑛,贾楠#. 动脉硬化性肾动脉狭窄相关临床试验的进展与分析. 中华高血压杂志,2010;18:1025-1028
12、Dong P, Xu Z, Jia N, Li D, Feng Y.. Elevated expression of p53 gain-of-function mutation R175H in endometrial cancer cells can increase the invasive phenotypes by activation of the EGFR/PI3K/AKT pathway.. Mol Cancer,2009;16(8):103.
13、Jia N#, Qiuping H, Wei J, Jianjun Z, Qiuyan D, Shaowen L. . Cardioprotective effects of granulocyte colony-stimulating factor in Angiotensin-II Induced Cardiac Remodeling.. Clin Exp Pharmacol Physiol,2009;36(3):262-266
14、Dong PX, Jia N, Xu ZJ, Liu YT, Li DJ, Feng YJ.. Silencing of IQGAP1 by shRNA inhibits the invasion of ovarian carcinoma HO-8910PM cells in vitro.. J Exp Clin Cancer Res,2008;27(1):77.
15、贾楠#,黄秋萍,金炜,张建军,戴秋艳,刘少稳. 粒细胞集落刺激因子对血管紧张素II所致小鼠心室肥厚的保护作用. 中华高血压杂志,2008;16(10):919-923
16、贾楠#,黄秋萍,金炜,孙宝贵. 奥美沙坦通过减低整合素β5的表达促进心肌肥大的消退. 中国心血管杂志,2007;2(12):12-17
17、贾楠#,黄秋萍,金炜,张建军,孙宝贵. 奥美沙坦与替莫普利合用对逆转左室肥厚无协同作用. 中华高血压杂志,2007;4(15):285-288
18、Matsui Y, Jia N*,Okamoto H, Kon S, Onozuka H, Akino M, Liu L, Morimoto J, Rittling SR, Denhardt D, Kitabatake A, Uede T. Role of osteopontin in cardiac fibrosis and remodeling in angiotensin II-induced cardiac hypertrophy . Hypertension,2004;43(6):1195-1201.
19、Matsui Y, Okamoto H, Jia N, Akino M, Uede T, Kitabatake A, Nishihira J . Blockade of macrophage migration inhibitory factor ameliorates experimental autoimmune myocarditis. Journal of Molecular and Cellular Cardiology,2004;37(2):557-566
20、Shimizu T, Okamoto H, Chiba S, Matsui Y, Sugawara T, Akino M, Jia N, Kumamoto H, Onozuka H, Mikami T, Kitabatake A. . VEGF-mediated angiogenesis is impaired by angiotensin type 1 receptor blockade in cardiomyopathic hamster hearts.. Cardiovascular research,2003;58(1):203-212
21、Matsui Y, Okamoto H, Inobe M, Jia N, Shimizu T, Akino M, Sugawara T, Tezuka K, Nakayama Y, Morimoto J, Kimura C, Kon S, Miyazaki T, Kitabatake A, Uede T.. Adenovirus-Mediated Gene Transfer of ICOSIg Fusion Protein Ameliorates Ongoing Experimental Autoimmune Myocarditis.. Human gene therapy,2003;14(6):521-532
22、Matsui Y, Rittling SR, Okamoto H, Inobe M, Jia N, Shimizu T, Akino M, Sugawara T, Morimoto J, Kimura C, Kon S, Denhardt D, Kitabatake A, Uede T. . Osteopontin Deficiency Attenuates Atherosclerosis in Female Apolipoprotein E-Deficient Mice.. Arteriosclerosis thrombosis and vascular biology,2003;23(6):1029-1034
23、Jia N, Okamoto H, Shimizu T, Chiba S, Matsui Y, Sugawara T, Akino M, Kitabatake A.. A Newly Developed Angiotensin II Type 1 Receptor Antagonist, CS866, Promotes Regression of Cardiac Hypertrophy by Reducing Beta-1 Integrin Expression.. Hypertension Research,2003;26:737-742
24、Jia N#, Okamoto H, Kitabatake A. . Integrin Beta-1 Results in Cardiac Hypertrophy Through Angiotensin II Type 1 Receptor. Journal of Molecular and Cellular Cardiology,2003;34(10):A17
25、Jia N#, Okamoto H, Matsui Y, Sugawara T, Akino M, Kitabatake A. Kitabatake A. . A Newly Developed Angiotensin II Type 1 Receptor Antagonist, CS866, Promotes Regression of Cardiac Hypertrophy by Reducing Beta-1 Integrin Expression. Journal of Cardiac Failure,2003;9(5):S187-187
26、Jia N#, Okamoto H, Kon S, Matsui Y, Akino M, Sugawara T, Uede T, Kitabatake A.. Osteopontin Is Essential for Cardiac Fibrosis in Angiotensin II-Induced Hypertrophy. Journal of Cardiac Failure,2003;9(5):S146-146
27、Matsui Y, Okamoto H, Inobe M, Jia N*, Akino M, Sugawara T, Kon S, Uede T. . Osteopontin Deficiency Attenuates Atherosclerosis in Female Apolipoprotein E Deficient Mice. Circulation,2003;108(17):IV-21
28、Matsui Y, Okamoto H, Inobe M, Jia N*, Akino M, Sugawara T, Kon S, Uede T. . Adenovirus-Mediated Gene Transfer of ICOSIg Fusion Protein Ameliorates Ongoing Experimental Autoimmune Myocarditis. . Circulation,2003;108(17):IV-518
29、Jia N#, Akino M, Okamoto H, Watanabe M, Kitabatake A. . Changing Prognosis in Dilated Cardiomyopathy. Circulation Journal,2002;.66 Suppl: 723.
30、Okamoto H, Jia N, Sugawara T, Matsui Y, Shimizu T, Akino M, Chiba S. Kitabatake A.. Changing Prognosis in Japanese Patients with Dilated Cardiomyopathy. . Circulation,2002;106(19):751-751